{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T15:20:02Z","timestamp":1778599202258,"version":"3.51.4"},"reference-count":36,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2006,11,3]],"date-time":"2006-11-03T00:00:00Z","timestamp":1162512000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2007,2]]},"abstract":"<jats:sec><jats:title>Summary<\/jats:title><\/jats:sec><jats:sec><jats:title>Background<\/jats:title><jats:p>Gastro\u2010oesophageal reflux is thought to cause chronic laryngitis through laryngopharyngeal reflux. Response of laryngitis to treatment with acid\u2010suppressive therapy supports this causal link.<\/jats:p><\/jats:sec><jats:sec><jats:title>Aim<\/jats:title><jats:p>To determine the prevalence of gastro\u2010oesophageal reflux disease in patients with chronic laryngitis and response to proton\u2010pump inhibitor therapy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Patients with chronic laryngitis were recruited. The frequency and severity of reflux and laryngeal symptoms were scored and laryngitis graded by laryngoscopy. All patients underwent esophagogastroduodenoscopy and 24\u2010h ambulatory pH monitoring before receiving lansoprazole 30\u2003mg b.d. for 8\u2003weeks.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The prevalence of gastro\u2010oesophageal reflux disease was 65.6% (21 of 32). Based on positive pH test, the prevalence was 25% (eight of 32). The change in laryngeal symptom score and laryngitis grade was significantly higher in GERD compared with non\u2010GERD patients (<jats:italic>P<\/jats:italic>\u2003=\u20030.010 for both). The proportion of patients with marked\/moderate improvement in laryngeal symptoms were significantly higher in patients with reflux (14 of 21, 67%) compared to those without reflux (two of 11, 18%; <jats:italic>P<\/jats:italic>\u2003=\u20030.026).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The prevalence of gastro\u2010oesophageal reflux disease amongst our patients with chronic laryngitis was high. The response to treatment with proton\u2010pump inhibitors in patients with reflux disease compared to those without underlined the critical role of acid reflux in a subset of patients with chronic laryngitis.<\/jats:p><\/jats:sec>","DOI":"10.1111\/j.1365-2036.2006.03185.x","type":"journal-article","created":{"date-parts":[[2010,7,23]],"date-time":"2010-07-23T11:44:46Z","timestamp":1279885486000},"page":"287-295","source":"Crossref","is-referenced-by-count":53,"title":["Gastro\u2010oesophageal reflux disease in chronic laryngitis: prevalence and response to acid\u2010suppressive therapy"],"prefix":"10.1111","volume":"25","author":[{"given":"C. S.","family":"QUA","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. H.","family":"WONG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"GOPALA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. L.","family":"GOH","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,1,8]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1002\/lary.1991.101.s53.1"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0022215100148340"},{"key":"e_1_2_6_4_2","first-page":"38","article-title":"Ambulatory esophageal and hypopharyngeal pH monitoring in patients with hoarseness","volume":"85","author":"Katz PO","year":"1990","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0892-1997(02)00132-7"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1288\/00005537-196811000-00008"},{"key":"e_1_2_6_7_2","first-page":"1503","article-title":"Chronic hoarseness secondary to gastroesophageal reflux disease: documentation with 24\u2010h ambulatory pH monitoring","volume":"84","author":"Wiener GJ","year":"1989","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-4486.2006.01134.x"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.mlg.0000191463.67692.36"},{"key":"e_1_2_6_10_2","first-page":"778","article-title":"Predictors of outcome in an open label, therapeutic trial of high dose omeprazole in laryngitis","volume":"85","author":"Williams RBH","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_6_11_2","first-page":"2160","article-title":"Empiric trial of high\u2010dose omeprazole in patients with posterior laryngitis: a prospective study","volume":"92","author":"Wo JM","year":"1997","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.116.5.1257"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.1996.v111.pm8698230"},{"key":"e_1_2_6_14_2","first-page":"168","article-title":"Normal 24\u2010hour ambulatory proximal and distal gastroesophageal reflux parameters in Chinese","volume":"8","author":"Hu WH","year":"2002","journal-title":"Hong Kong Med J"},{"key":"e_1_2_6_15_2","first-page":"1","article-title":"Extraesophageal manifestations of gastroesophageal reflux disease","volume":"84","author":"Deschner WK","year":"1989","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000441-200311000-00005"},{"key":"e_1_2_6_17_2","first-page":"1321","volume-title":"Aliment Pharmacol Ther","author":"Wong CH","year":"2006"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1177\/000348940111001203"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(90)90945-W"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.111.5.1389"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005537-200110000-00013"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005537-200209000-00014"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1023\/B:DDAS.0000004513.27054.d0"},{"key":"e_1_2_6_24_2","first-page":"115","article-title":"Improvement in clinical course and laryngeal appearance in selected patients with chronic laryngitis after eight weeks of therapy with rabeprazole","volume":"10","author":"Klopocka M","year":"2004","journal-title":"Med Sci Monit"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0892-1997(02)00115-7"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005537-200304000-00003"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02358600"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0892-1997(96)80033-6"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0194-59989770350-4"},{"key":"e_1_2_6_30_2","first-page":"5650","article-title":"ENT disorders caused by GERD: efficacy of treatment with pantoprazole","volume":"18","author":"Fossati D","year":"2000","journal-title":"Gastroenterology"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2001.03681.x"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.otohns.2004.03.037"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.mlg.0000192173.00498.ba"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005537-200112000-00013"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1080\/00365520310001860"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2005.41183.x"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2006.02800.x"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2036.2006.03185.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2036.2006.03185.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T20:21:50Z","timestamp":1697228510000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2036.2006.03185.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1,8]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,2]]}},"alternative-id":["10.1111\/j.1365-2036.2006.03185.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2036.2006.03185.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,1,8]]}}}